DOI:
10.1055/s-00034925
Hämostaseologie
LinksClose Window
References
Shima M, Nogami K, Nagami S. et al.
A multicentre, open-label study of emicizumab given every 2 or 4 weeks in children with severe haemophilia A without inhibitors.
Haemophilia 2019;
25 (06) 979-987
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.